Dietary Supplements at the U.S. Border: HS 2106 vs. 3004, FDA Holds, and Why Most Brands Self-Classify Wrong

Vitamins, herbal blends, protein powders, probiotics, collagen products, and sports-nutrition supplements often arrive at the border in the same forms: tablets, capsules, softgels, gummies, and powders. Classification, however, is not determined by the form of the product. The key question is whether the product is treated as a dietary supplement under federal food law or as a medicament under the tariff schedule.

That distinction shapes how many dietary supplements are classified at the border. A multivitamin, herbal supplement, or collagen blend may look similar to a medicament, yet many products sold as dietary supplements follow an entirely different tariff path because of how they are defined under the FD&C Act and DSHEA.

The starting point for that analysis is Chapter 30, Note 1(a) of the HTSUS. Understanding how that note works resolves the classification question for a large share of dietary supplements before ingredient-specific analysis, FDA review considerations, or subheading selection even begins

The Legal Anchor: Chapter 30, Note 1(a) 

For most dietary supplements, the classification analysis starts and ends with a single question: Is the product a dietary supplement under federal food law? 

If the answer is yes, Chapter 30 usually stops being relevant.

Chapter 30, Note 1(a) states that the chapter does not cover foods, beverages, or food supplements, except for nutritional preparations administered intravenously. That means products that qualify as dietary supplements under Section 201(ff) of the FD&C Act are generally excluded from Chapter 30 and instead move into Chapter 21, where heading 2106 covers food preparations not elsewhere specified or included.

The key point is that form does not determine classification. A product does not become a medicament simply because it is sold as a tablet, capsule, softgel, or gummy. Customs looks first at the product's regulatory status and composition, not its dosage form.

CBP has applied this principle consistently across supplement classifications. In HQ 089455, for example, a vitamin-containing supplement was classified in heading 2106 because Chapter 30, Note 1(a) excludes food supplements from Chapter 30 even when vitamins are present.

The commercial impact is significant. Products classified under 2106.90.9898 generally carry a 6.4% duty rate, while certain vitamin medicaments classified under 3004.50 enter duty-free. Understanding when a product belongs in 2106 rather than 3004 is one of the most important classification decisions supplement importers make.

When Does 3004.50 Actually Apply? 

Many importers see the duty-free rate under 3004.50 and assume any vitamin product can be classified there. In practice, the category is much narrower.

A product generally needs to meet three conditions:

• Vitamins must provide the essential character of the product: The product should be primarily a vitamin preparation rather than a botanical, herbal, collagen, probiotic, or other supplement with added vitamins.

• The product must be sold in measured doses or retail packaging: Tablets, capsules, softgels, and similar retail-ready presentations typically satisfy this requirement.

• The product must not qualify as a dietary supplement under DSHEA: If it falls within the statutory definition of a dietary supplement, Chapter 30, Note 1(a) generally directs the product away from heading 3004 and back toward Chapter 21.

As a result, products that successfully classify under 3004.50 tend to be pure or substantially pure vitamin preparations where vitamins are the primary reason consumers buy the product.

Many products that appear similar at first glance do not meet that standard. A multivitamin blended with elderberry, a collagen product fortified with vitamin C, or a vitamin-and-botanical formula marketed as a dietary supplement will generally remain within the supplement classification framework rather than the medicament provisions.

The distinction matters because the duty treatment can be very different. Products classified under 2106.90.9898 generally carry a 6.4% duty rate, while qualifying products under 3004.50 enter duty-free. Understanding where that line sits is one of the most important classification decisions supplement importers make.

Six Places Brands Self-Classify Wrong 

Several classification mistakes appear repeatedly across dietary supplement imports. Most stem from focusing on product form or marketing language rather than the rules that actually drive classification.

1. Treating tablet or capsule form as a classification factor

Many supplement products are sold in measured doses, but that alone does not make them medicaments. Chapter 30, Note 1(a) excludes food supplements from Chapter 30 regardless of whether they are sold as tablets, capsules, softgels, gummies, or powders. CBP has repeatedly classified supplement products under heading 2106 despite their dosage form.

2. Assuming vitamins automatically create a medicament

The presence of vitamins does not automatically support classification under 3004.50. Vitamins must provide the essential character of the product. A botanical blend, collagen formula, or herbal supplement with added vitamins remains a supplement if the vitamins are not the primary reason the product is marketed and consumed.

3. Relying on the supplier's HS code

Suppliers often provide tariff classifications based on their local tariff schedules or generic product descriptions. The importer of record remains responsible for the U.S. classification. Supplier-provided codes should be treated as a starting point, not a final determination.

4. Filing protein powders under 2106.10 without verifying eligibility

Protein powders are frequently classified under 2106.10 as protein concentrates without confirming that the product satisfies the requirements of that provision. Products that fail the threshold may belong elsewhere within heading 2106, creating avoidable entry corrections and compliance issues.

5. Skipping FDA Import Alert reviews before shipment

Classification is only one part of the import process. Dietary supplements can also be affected by FDA Import Alerts covering GMP violations, prohibited ingredients, active pharmaceutical ingredients, or inadequate safety information. Reviewing applicable alerts before shipping helps identify issues before the product reaches the port.

6. Using disease claims in product marketing

A product marketed to diagnose, treat, cure, or prevent a disease can move outside the dietary supplement framework and into the FDA's drug-regulation regime. Product labels, websites, and marketing materials should be reviewed alongside classification decisions because regulatory claims can affect how the product is treated at the border.

Where Do FDA Import Alerts Intersect with CBP Entry? 

Classification and FDA admissibility are closely connected during the import process. CBP and FDA share entry data through the International Trade Data System, and FDA uses that information to determine how a shipment should be reviewed. A dietary supplement entered under heading 2106 is generally reviewed within the food and dietary supplement framework, while a product entered under heading 3004 may be routed through a drug-review process.

Because of that connection, a classification decision can influence more than duty liability. An incorrectly classified supplement may face additional FDA scrutiny, creating delays and compliance issues that extend beyond the customs entry itself.

FDA review also operates under an "appearance standard" under Section 801(a) of the FD&C Act. The agency does not need to establish a violation before taking action. If a shipment appears to violate FDA requirements, it may be detained while the importer provides supporting documentation or other evidence. Products that cannot satisfy FDA requirements may ultimately be refused admission.

Import readiness extends beyond classification. Facility registration, FSVP requirements, ingredient compliance, and FDA Import Alerts should all be reviewed before the first shipment moves. A correctly classified product can still encounter delays if supporting FDA requirements have not been satisfied.

Prior notice is another critical checkpoint. FDA regulations establish minimum filing timeframes before arrival, including 2 hours for road shipments, 4 hours for air and rail shipments, and 8 hours for ocean shipments. Missing those deadlines can result in shipment delays regardless of whether the product classification and facility documentation are otherwise correct. For many importers, prior notice works best when it is built into the shipment-preparation process rather than treated as a final pre-arrival task.

An Audit-Ready Classification Workflow 

A workflow that survives a CBP audit applies Note 1(a) before doing anything else. The order matters because most supplements never need the rest of the steps.

1. List every ingredient by regulatory category (vitamin, mineral, botanical, amino acid, probiotic, protein concentrate, novel dietary ingredient).

2. Read the label verbatim. Capture every claim. Determine whether the product qualifies as a DSHEA dietary supplement.

3. Apply Chapter 30, Note 1(a). If the product is a food supplement, Chapter 30 is closed; proceed to step 6.

4. Only if the product is not a food supplement, test heading 3004 against the four US Additional Note criteria (disease indication on packaging, concentration, dosage, method of administration).

5. For products that meet step 4, verify that vitamins of heading 2936 are the essential characteristic if 3004.50 is the target.

6. Within Chapter 21, pick the correct subheading: 2106.10 if protein content meets the concentrate threshold; 2106.90.58 for products put up in gelatin form; 2106.90.9898 or 2106.90.9998 for other food preparations not elsewhere specified.

7. Search CROSS at rulings.cbp.gov for prior rulings on similar merchandise and review the analytical path CBP applied.

8. For new or ambiguous products, file a binding ruling request at apps.cbp.gov/erulings before commercial shipments begin.

A binding ruling is legally binding only for the specific importer and merchandise described, but it eliminates classification risk going forward. The 30-day turnaround is cheap insurance for a borderline combination product.

Self-Classify Supplements Without Bleeding Duty 

Audit-ready supplement programs share a simple habit: they start with Chapter 30, Note 1(a) before reviewing any heading text. Applying that rule to the product's ingredient list, labeling, and intended use resolves the classification question for most dietary supplements without the need for a binding ruling.

The remaining cases tend to be the difficult ones: vitamin-botanical combinations, novel adaptogens with limited ruling history, and protein products that sit close to the 2106.10 threshold. Those products often justify additional review before import.

Strong compliance programs also treat customs and FDA requirements as part of the same workflow. Facility registration, import-alert screening, prior notice filing, ingredient review, and HTS classification all influence whether a shipment moves smoothly through the border process.

Gaia helps you evaluate supplement classifications against ingredient composition, product claims, and regulatory status before products are imported. From DSHEA qualification and Chapter 30 exclusions to protein powders, botanical blends, and vitamin formulations, we help teams navigate the classification questions that most commonly trigger duty and admissibility issues.

Frequently Asked Questions

Why does a multivitamin in capsule form classify as a food preparation rather than a medicament?

Dosage form does not control classification. Chapter 30, Note 1(a) excludes food supplements from Chapter 30, so a multivitamin marketed as a dietary supplement under DSHEA generally classifies in heading 2106 regardless of whether it is sold as a tablet, capsule, or softgel.

When can a vitamin product legitimately classify under 3004.50?

A product generally needs to satisfy three conditions: vitamins must provide the essential character of the product, it must be sold in measured retail doses, and it must not qualify as a dietary supplement under DSHEA. Pure or substantially pure vitamin preparations have the clearest path to classification under 3004.50.

What happens if a supplement is misclassified under 3004 instead of 2106?

Misclassification can create both customs and FDA issues. CBP may assess additional duties and penalties, while FDA may review the product under a drug framework that the product was never intended to satisfy.

How far back can CBP review a supplement misclassification?

CBP can generally recover duties and assess penalties on entries going back up to five years under 19 U.S.C. § 1592. The financial impact often comes from repeated classification errors across multiple shipments rather than a single entry.

Can a protein powder automatically classify under 2106.10?

No. Products must satisfy the requirements of the subheading. Protein powders that do not meet the applicable threshold may belong elsewhere within heading 2106, making formulation review an important part of the classification process.